SLC6A3 and Parkinson disease: Based on these premises, rather than revisiting the largely established role of advanced age at PD onset and caudate dopaminergic denervation in PD-related cognitive deficits, our objective was to evaluate the potential association between early cognitive decline in these patients and the decline in caudate DAT availability that is associated with the normal aging process.